Reneo Pharmaceuticals Inc (RPHM)

Finanzdaten der Reneo Pharmaceuticals Inc-Aktie (RPHM)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	61.75% 9.564	25.01	20.89	21.04	16.12
Operating Income/Loss	61.75% -9.564	-25.01	-20.89	-21.04	-16.12
Income/Loss From Continuing Operations Before Tax	64.23% -8.426	-23.55	-19.20	-19.53	-15.11
Income/Loss From Continuing Operations After Tax	64.23% -8.426	-23.55	-19.20	-19.53	-15.11
Net Income/Loss	64.23% -8.426	-23.55	-19.20	-19.53	-15.11
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,389% 33.42	0.9578	33.81	30.22	25.04
Diluted Average Shares	3,389% 33.42	0.9578	33.81	30.22	25.04
Basic Earnings Per Share	64.79% -0.25	-0.71	-0.57	-0.65	-0.60
Diluted Earnings Per Share	64.79% -0.25	-0.71	-0.57	-0.65	-0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-